{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T15:09:52Z","timestamp":1695568192391},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s10165-011-0436-5","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T18:34:01Z","timestamp":1299695641000},"page":"548-552","source":"Crossref","is-referenced-by-count":3,"title":["Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene"],"prefix":"10.1093","volume":"21","author":[{"given":"Yohei","family":"Ichimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenshiro","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Takekoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Kogure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,3,10]]},"reference":[{"key":"436_CR1","unstructured":"Abraham DJ, Krieg T, Distler J, Distler O. Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) 2009;48(Suppl 3):iii3\u20137."},{"key":"436_CR2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2133.2006.07475.x","volume":"155","author":"M Hasegawa","year":"2006","unstructured":"Hasegawa M, Nagai Y, Tamura A, Ishikawa O. Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis. Br J Dermatol. 2006;155:1159\u201364.","journal-title":"Br J Dermatol"},{"key":"436_CR3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.57.8.476","volume":"57","author":"L Stafford","year":"1998","unstructured":"Stafford L, Englert H, Gover J, Bertouch J. Distribution of macrovascular disease in scleroderma. Ann Rheum Dis. 1998;57:476\u20139.","journal-title":"Ann Rheum Dis"},{"key":"436_CR4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/ard.52.6.464","volume":"52","author":"P Youssef","year":"1993","unstructured":"Youssef P, Englert H, Bertouch J. Large vessel occlusive disease associated with CREST syndrome and scleroderma. Ann Rheum Dis. 1993;52:464\u20136.","journal-title":"Ann Rheum Dis"},{"key":"436_CR5","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","volume":"50","author":"JH Korn","year":"2004","unstructured":"Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum. 2004;50:3985\u201393.","journal-title":"Arthritis Rheum"},{"key":"436_CR6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2008.096677","volume":"68","author":"O Kowal-Bielecka","year":"2009","unstructured":"Kowal-Bielecka O, Landewe R, Avouac J, Chwiesko S, Miniati I, Czirjak L, et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis. 2009;68:620\u20138.","journal-title":"Ann Rheum Dis"},{"key":"436_CR7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-73-2-317","volume":"73","author":"WL Norton","year":"1970","unstructured":"Norton WL, Nardo JM. Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med. 1970;73:317\u201324.","journal-title":"Ann Intern Med"},{"key":"436_CR8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0049-0172(75)90017-7","volume":"4","author":"PM Campbell","year":"1975","unstructured":"Campbell PM, LeRoy EC. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum. 1975;4:351\u201368.","journal-title":"Semin Arthritis Rheum"},{"key":"436_CR9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","volume":"46","author":"WA D\u2019Angelo","year":"1969","unstructured":"D\u2019Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med. 1969;46:428\u201340.","journal-title":"Am J Med"},{"issue":"Suppl 3","key":"436_CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2362.2006.01695.x","volume":"36","author":"K Ahmadi-Simab","year":"2006","unstructured":"Ahmadi-Simab K, Hellmich B, Gross WL. Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease. Eur J Clin Invest. 2006;36(Suppl 3):44\u20138.","journal-title":"Eur J Clin Invest"},{"issue":"Suppl 3","key":"436_CR11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2362.2006.01684.x","volume":"36","author":"F Cozzi","year":"2006","unstructured":"Cozzi F, Montisci R, Marotta H, Bobbo F, Durigon N, Ruscazio M, et al. Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases. Eur J Clin Invest. 2006;36(Suppl 3):49\u201353.","journal-title":"Eur J Clin Invest"},{"key":"436_CR12","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/ard.2007.079921","volume":"67","author":"CP Denton","year":"2008","unstructured":"Denton CP, Pope JE, Peter HH, Gabrielli A, Boonstra A, van den Hoogen FH, et al. Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases. Ann Rheum Dis. 2008;67:1222\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 3","key":"436_CR13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2362.2006.01688.x","volume":"36","author":"VV McLaughlin","year":"2006","unstructured":"McLaughlin VV. Survival in patients with pulmonary arterial hypertension treated with first-line bosentan. Eur J Clin Invest. 2006;36(Suppl 3):10\u20135.","journal-title":"Eur J Clin Invest"},{"key":"436_CR14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1165\/ajrcmb.11.4.7917311","volume":"11","author":"AD Cambrey","year":"1994","unstructured":"Cambrey AD, Harrison NK, Dawes KE, Southcott AM, Black CM, du Bois RM, et al. Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro. Am J Respir Cell Mol Biol. 1994;11:439\u201345.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"436_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.100.1.5","volume":"100","author":"Z Yang","year":"1999","unstructured":"Yang Z, Krasnici N, Luscher TF. Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade. Circulation. 1999;100:5\u20138.","journal-title":"Circulation"},{"key":"436_CR16","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1091\/mbc.E03-12-0902","volume":"15","author":"X Shi-Wen","year":"2004","unstructured":"Shi-Wen X, Chen Y, Denton CP, Eastwood M, Renzoni EA, Bou-Gharios G, et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac\/phosphoinositide 3-kinase\/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell. 2004;15:2707\u201319.","journal-title":"Mol Biol Cell"},{"key":"436_CR17","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/ard.2007.080424","volume":"67","author":"F Iannone","year":"2008","unstructured":"Iannone F, Riccardi MT, Guiducci S, Bizzoca R, Cinelli M, Matucci-Cerinic M, et al. Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension. Ann Rheum Dis. 2008;67:1121\u20136.","journal-title":"Ann Rheum Dis"},{"key":"436_CR18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1183\/09059180.00010907","volume":"17","author":"D Abraham","year":"2008","unstructured":"Abraham D. Role of endothelin in lung fibrosis. Eur Respir Rev. 2008;17:145\u201350.","journal-title":"Eur Respir Rev"},{"key":"436_CR19","first-page":"1838","volume":"21","author":"R Vancheeswaran","year":"1994","unstructured":"Vancheeswaran R, Magoulas T, Efrat G, Wheeler-Jones C, Olsen I, Penny R, et al. Circulating endothelin-1 levels in systemic sclerosis subsets\u2013\u2013a marker of fibrosis or vascular dysfunction? J Rheumatol. 1994;21:1838\u201344.","journal-title":"J Rheumatol"},{"key":"436_CR20","first-page":"1566","volume":"19","author":"K Yamane","year":"1992","unstructured":"Yamane K, Miyauchi T, Suzuki N, Yuhara T, Akama T, Suzuki H, et al. Significance of plasma endothelin-1 levels in patients with systemic sclerosis. J Rheumatol. 1992;19:1566\u201371.","journal-title":"J Rheumatol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0436-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:18Z","timestamp":1646843118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0436-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["436"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0436-5","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,10]]}}}